Congenica LTD is a limited liability company established in 2012 and currently active. Located at Bic Wellcome Genome Campus in Cambridge, CB10 1DR, the company specializes in providing precision genomic interpretation services to laboratories worldwide. Congenica’s core business revolves around assisting researchers and clinicians in analyzing genetic data to enhance patient outcomes. The company’s primary service focuses on streamlining variant analysis, a critical component of genomic research and diagnostics. Congenica offers tools and expertise designed to accelerate the interpretation of genetic variations, reducing time-to-results and improving diagnostic accuracy. They also provide solutions for optimizing diagnostic workflows and facilitating the identification of actionable insights from genomic data. Congenica’s international presence is significant, serving laboratories across North America, Europe, and Asia. The company employs a team of skilled professionals, including genomic analysts and technical support specialists, and actively recruits talented individuals. Congenica’s strategic focus is on improving patient outcomes through the application of advanced genomic technologies. The company operates under SIC codes relating to research and experimental development on biotechnology.

Congenica LTD is a limited liability company established in 2012 and currently active. Located at Bic Wellcome Genome Campus in Cambridge, CB10 1DR, the company specializes in providing precision genomic interpretation services to laboratories worldwide. Congenica’s core business revolves around assisting researchers and clinicians in analyzing genetic data to enhance patient outcomes. The company’s primary service focuses on streamlining variant analysis, a critical component of genomic research and diagnostics. Congenica offers tools and expertise designed to accelerate the interpretation of genetic variations, reducing time-to-results and improving diagnostic accuracy. They also provide solutions for optimizing diagnostic workflows and facilitating the identification of actionable insights from genomic data. Congenica’s international presence is significant, serving laboratories across North America, Europe, and Asia. The company employs a team of skilled professionals, including genomic analysts and technical support specialists, and actively recruits talented individuals. Congenica’s strategic focus is on improving patient outcomes through the application of advanced genomic technologies. The company operates under SIC codes relating to research and experimental development on biotechnology.